The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO GI 2023 | Novel insights in the role of transplantation in liver cancer
Gonzalo Sapisochin, MD, Toronto General Hospital, Toronto, CA, comments on the future role of liver transplantation in patients with liver cancer. Advances in the treatment landscape, including the advent of systemic therapies and immunotherapy, may increase the proportion of patients eligible for transplant. Techniques such as liquid biopsies and ctDNA analysis will additionally benefit clinicians in the decision making process. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Gastrointestinal Cancers (GI) Symposium in San Francisco, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
